Recent results of immunotherapy and perspectives for advanced NSCLC

Por Jardim, Denis L, de Melo Gagliato, Debora
Publicado no Lung Cancer Manag (2016)

Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA—clinical utility, current limitations and future perspectives

Por de Melo Gagliato, Debora, Fontes Jardim, Denis L.
Publicado no Ann Transl Med (2018)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology

Por Jardim, Denis L., de Melo Gagliato, Débora, Kurzrock, Razelle
Publicado no Integr Cancer Ther (2018)

Analysis of Drug Development Paradigms for Immune Checkpoint inhibitors

Por Jardim, Denis L., de Melo Gagliato, Débora, Giles, Francis J., Kurzrock, Razelle
Publicado no Clin Cancer Res (2017)

Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds

Por Jardim, Denis L., De Melo Gagliato, Débora, Nikanjam, Mina, Barkauskas, Donald A., Kurzrock, Razelle
Publicado no Oncoimmunology (2020)

Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer

Por de Melo Gagliato, Debora, Leonardo Fontes Jardim, Denis, Marchesi, Mario Sergio Pereira, Hortobagyi, Gabriel N.
Publicado no Oncotarget (2016)

Bevacizumab as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer: A Brazilian Center Experience

Por Jardim, Denis Leonardo Fontes, de Melo Gagliato, Débora, Ribeiro, Karina Braga, Shimada, Andrea Kazumi, Katz, Artur
Publicado em 2012

Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer

Por de Melo Gagliato, Debora, Lei, Xiudong, Giordano, Sharon H., Valero, Vicente, Barcenas, Carlos H., Hortobagyi, Gabriel N., Chavez‐MacGregor, Mariana
Publicado no Oncologist (2020)

Cardiac Safety of (Neo)Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience

Por da Fonseca, Leonardo Gomes, de Melo Gagliato, Debora, Takahashi, Tiago K., Mak, Milena Perez, Barroso-Sousa, Romualdo, Testa, Laura, Helena, Vanessa Petry, de Paula Costa, Romulo, Hoff, Paulo M., Mano, Max S.
Publicado em 2014

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes

Por Chavez-MacGregor, Mariana, Liu, Shuying, De Melo-Gagliato, Debora, Chen, Huiqin, Do, Kim-Anh, Pusztai, Lajos, Symmans, W. Fraser, Nair, Lakshmy, Hortobagyi, Gabriel N., Mills, Gordon B., Meric-Bernstam, Funda, Gonzalez-Angulo, Ana M.
Publicado em 2013

Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit

Por de Melo Gagliato, Debora, Fontes Jardim, Denis L., Falchook, Gerald, Tang, Chad, Zinner, Ralph, Wheler, Jennifer J., Janku, Filip, Subbiah, Vivek, Piha-Paul, Sarina A., Fu, Siqing, Hess, Kenneth, Roy-Chowdhuri, Sinchita, Moulder, Stacy, Gonzalez-Angulo, Ana M., Meric-Bernstam, Funda, Hong, David S.
Publicado no Clin Breast Cancer (2014)

MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors

Por Jardim, Denis L. F., de Melo Gagliato, Débora, Falchook, Gerald, Zinner, Ralph, Wheler, Jennifer J., Janku, Filip, Subbiah, Vivek, Piha-Paul, Sarina A., Fu, Siqing, Tannir, Nizar, Corn, Paul, Tang, Chad, Hess, Kenneth, Roy-Chowdhuri, Sinchita, Kurzrock, Razelle, Meric-Bernstam, Funda, Hong, David S.
Publicado no Clin Genitourin Cancer (2014)

Clinical outcomes based on multigene profiling in metastatic breast cancer patients

Por Basho, Reva K., de Melo Gagliato, Debora, Ueno, Naoto T., Wathoo, Chetna, Chen, Huiqin, Shariati, Maryam, Wei, Caimiao, Alvarez, Ricardo H., Moulder, Stacy L., Sahin, Aysegul A., Roy-Chowdhuri, Sinchita, Chavez-MacGregor, Mariana, Litton, Jennifer K., Valero, Vincent, Luthra, Raja, Zeng, Jia, Shaw, Kenna R., Mendelsohn, John, Mills, Gordon B., Tripathy, Debu, Meric-Bernstam, Funda
Publicado no Oncotarget (2016)